Table 1.
The comparison of demographic and past medical history between the studied groups.
| Variable | Case (N = 301) | Control (N = 301) | P value |
|---|---|---|---|
| Age (years) | 58.40 ± 0.49 | 59.02 ± 0.45 | 0.352 |
|
Sex n (%) | |||
| Male | 190 (63.12%) | 197 (65.45%) | 0.552 |
| Female | 111 (36.88%) | 104 (34.55%) | |
| BMI (kg/m2) | 28.51 ± 0.09 | 28.52 ± 0.09 | 0.600 |
| 1st day lymphocyte count (n/µl) | 917.34 ± 190.34 | 927.63 ± 203.89 | 0.197 |
|
HTN n (%) | |||
| Yes | 161 (53.49%) | 161 (53.49%) | 1.000 |
| No | 140 (46.51%) | 140 (46.51%) | |
|
DM n (%) | |||
| Yes | 92 (30.56%) | 93 (30.9%) | 0.930 |
| No | 209 (69.44%) | 208 (69.1%) | |
|
IHD n (%) | |||
| Yes | 48 (15.95%) | 48 (15.95%) | 0.782 |
| No | 253 (84.05%) | 253 (84.05%) | |
|
CKD n (%) | |||
| Yes | 22 (7.3%) | 23 (7.6%) | 0.877 |
| No | 279 (92.7%) | 278 (92.4%) | |
| Chronic respiratory disease n (%) | |||
| Yes | 137 (45.51%) | 139 (46.18%) | 0.870 |
| No | 164 (54.49%) | 162 (53.82%) | |
| Immunosuppressive disease n (%) | |||
| Yes | 17 (5.65%) | 17 (5.65%) | 1.000 |
| No | 284 (94.35%) | 284 (94.35%) | |
| One dose vaccination n (%) | |||
| Yes | 207 (68.77%) | 210 (69.77%) | 0.791 |
| No | 94 (31.23%) | 91 (30.23%) | |
| Two dose vaccination n (%) | |||
| Yes | 130 (43.19%) | 136 (45.18%) | 0.623 |
| No | 171 (56.81%) | 165 (54.82%) | |
| Vaccine type n (%) | |||
| 0 (None) | 94 (31.23%) | 91 (30.23%) | 0.798 |
| 1 (Sinopharm) | 94 (31.23%) | 83 (27.57%) | |
| 2 (Astrazeneca) | 53 (17.61%) | 63 (20.93%) | |
| 3 (CovIranBarakat) | 27 (8.97%) | 44 (14.62%) | |
| 4 (Other) | 33 (10.96%) | 20 (6.64%) | |
BMI body mass index, HTN hypertension, DM diabetes mellitus, IHD Ischemic heart disease, CKD chronic kidney disease.